Brief: Sutro Biopharma Reports Third Quarter 2022 Financial Results

Sutro Biopharma

08/11/2022 21:48

Nov 8 (Reuters) - Sutro Biopharma Inc  STRO.O :
    * SUTRO BIOPHARMA REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS,
BUSINESS HIGHLIGHTS AND SELECT ANTICIPATED MILESTONES
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF
JUNE 30,
2022 PROVIDES A PROJECTED CASH RUNWAY INTO FIRST HALF OF 2024
    * Q3 REVENUE $25.1 MILLION VERSUS $8.5 MILLION
    * Q3 EARNINGS PER SHARE VIEW $-0.74, REVENUE VIEW $12.7
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6hy4f3 
Further company coverage:  STRO.O 
 ((Reuters.Briefs@thomsonreuters.com;))